Seinepharma

Founded: 2020 • Age: 6 yrs
Manufactures high-purity API impurities, standards, and chemical compounds for pharmaceuticals.

About Seinepharma

Seinepharma is a Chemicals & Materials company founded in 2020. It manufactures high-purity API impurities, standards, and chemical compounds for pharmaceuticals. It operates on a B2B model. The company has 1 employees. Its Indian entity Seine Pharma Private Limited reported revenue of β‚Ή1.71 Cr. Seinepharma offers products and services including API Standards, API Impurities, Building Blocks, and Deuterated Compounds. Its focus areas include Chemicals and Materials, Pharmaceutical Chemicals, API Standards and Impurities.

Company details

Seine Pharma Specializes In Synthesizing, Isolating, And Purifying Api Impurities, Standards, And Related Compounds. Based In Hyderabad, India, They Supply High-purity Products On Scales From Milligrams To Grams For The Pharmaceutical Sector. Their Services Include Technical Support And Characterization Of Impurities, Serving Global Pharmaceutical Companies With A Focus On Quality And Compliance.

  • Employees 1
  • Sectors
    Chemicals & Materials
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website seinepharma.com
  • Social LinkedIn Facebook
  • Legal Name Seine Pharma Pvt Ltd
  • Date of Incorporation 07 Sep, 2020
  • Jurisdiction Hyderabad, Telangana, India
Key Metrics
  • Indian entity revenue
    ₹1.71 Cr

    FY 2024 · -34% YoY

  • Indian entity net profit
    ₹5.8 Lakh

    FY 2024 · 3% margin

  • Indian entity EBITDA
    ₹8.6 Lakh

    FY 2024 · 5% margin

  • Employee Count
    1

Products & Services of Seinepharma

Seinepharma offers a comprehensive portfolio of products and services, including API Standards, API Impurities, Building Blocks, and Deuterated Compounds.

API Standards
Chemical Standards

High-purity standards for pharmaceutical API validation

API Impurities
Impurities

Isolation and characterization of pharmaceutical impurities

Building Blocks
Chemical Compounds

Organic compounds for synthesis in drug development

Deuterated Compounds
Specialty Chemicals

Labeled compounds for research applications

Board of directors of Seine Pharma Private Limited (Seinepharma)

Seine Pharma Private Limited is the primary company behind Seinepharma. The board of Seine Pharma Private Limited currently have 3 directors; the longest-serving is Venkata Krishna Reddy Chittireddy, appointed in 2020.

DirectorDesignationAppointedTenureEntity
Venkata Krishna Reddy Chittireddy
DIN 06729035
Director07 Sep 20206 yrs 1 moSeine Pharma Private Limited
Naveen Kumar Reddy Kotla
DIN 08866593
Director07 Sep 20206 yrs 1 moSeine Pharma Private Limited
Naveen Kumar Reddy Kunchala
DIN 08866562
Director07 Sep 20206 yrs 1 moSeine Pharma Private Limited

Financials of Seinepharma

Figures of Seine Pharma Private Limited, the primary company behind Seinepharma, for FY 2024. Revenue was ₹1.71 Cr (-34% year on year). Net profit was ₹5.8 Lakh (3% margin). EBITDA was ₹8.6 Lakh (5% margin). Revenue has grown at a compounded annual rate of +85% over three years.

  • ₹1.71 CrRevenue · FY 2024 · -34% YoY
  • ₹5.8 LakhNet profit · 3% margin
  • ₹8.6 LakhEBITDA · 5% margin
  • ₹1.2 LakhPaid-up capital
  • +85%Revenue CAGR, 3 years

Balance sheet, profit and loss, cash flow and ratios of Seine Pharma Private Limited are on its company page.

Premium access

Detailed financial statements for Seinepharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Seinepharma

Seinepharma was founded in 2020.

Seinepharma has 1 employees.

The primary company behind Seinepharma, Seine Pharma Private Limited, reported revenue of β‚Ή1.71 Cr for FY 2024, down 34% year on year.

Seine Pharma Specializes In Synthesizing, Isolating, And Purifying Api Impurities, Standards, And Related Compounds. Based In Hyderabad, India, They Supply High-purity Products On Scales From Milligrams To Grams For The Pharmaceutical Sector. Their Services Include Technical Support And Characterization Of Impurities, Serving Global Pharmaceutical Companies With A Focus On Quality And Compliance.

Seinepharma offers API Standards, API Impurities, Building Blocks, and Deuterated Compounds.

Seinepharma operates through Seine Pharma Private Limited.

The legal entities of Seinepharma currently have 3 directors, including Venkata Krishna Reddy Chittireddy, Naveen Kumar Reddy Kotla, Naveen Kumar Reddy Kunchala.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available